Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

October 31, 2032

Study Completion Date

October 31, 2032

Conditions
SarcopeniaCOPDILD
Interventions
DIETARY_SUPPLEMENT

Sarcojoint®

All participants are administered Sarcojoint® containing leucinine 1 g, arginine 1.5 g, Vitamin D 7.5μg, chondroitin 400 mg, calcium 300 mg, and glucosamine 700 mg per package, and take 1 package twice a day.

BEHAVIORAL

supervised exercise

All participants are required to walk 6500 steps every day for 12 weeks, and the data are recorded by Xiaomi-smart-band.

Trial Locations (1)

Unknown

RECRUITING

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
lead

Orient Europharma Co., Ltd.

INDUSTRY